Eliem Therapeutics, Inc

/Eliem Therapeutics, Inc

IPO

Eliem Therapeutics, Inc

Biotechnology

We are a clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems.

Symbol

ELYM

Price Range
$12.50 - $12.50

Final Shares
4,500,000

Anticipated Date
August 10, 2021

Underwriters
LEERINK SWANN & COMPANY

This offering is no longer available

To view the prospectus for Eliem Therapeutics, Inc IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange